两部委发文:医疗器械临床试验机构将实行备案管理

2017-11-25 陈聪 新华社

新华社北京11月24日电 记者24日从国家食品药品监督管理总局了解到,食药监总局近日会同国家卫生计生委联合发布《医疗器械临床试验机构条件和备案管理办法》。根据办法,将对符合医疗器械临床试验质量管理规范要求、具备开展医疗器械临床试验相应的水平和能力的医疗器械临床试验机构施行备案管理。食药监总局有关司局负责人表示,根据《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》等有关规定,医疗器械临床试验机

新华社北京11月24日电 记者24日从国家食品药品监督管理总局了解到,食药监总局近日会同国家卫生计生委联合发布《医疗器械临床试验机构条件和备案管理办法》。根据办法,将对符合医疗器械临床试验质量管理规范要求、具备开展医疗器械临床试验相应的水平和能力的医疗器械临床试验机构施行备案管理。

食药监总局有关司局负责人表示,根据《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》等有关规定,医疗器械临床试验机构由原先的资质认定改为备案管理。据介绍,临床试验机构实行备案管理,有利于释放临床资源,扩大临床试验机构的数量,更好地满足医疗器械临床试验的需求。

办法提出,医疗器械临床试验机构应当具备具有医疗机构执业资格、具有二级甲等以上资质、具有医疗器械临床试验管理制度和标准操作规程等十一项条件。

根据办法,食药监总局组织建立医疗器械临床试验机构备案管理信息系统,用于开展医疗器械临床试验机构备案管理工作。医疗器械临床试验机构应当根据办法要求,对本单位是否具备医疗器械临床试验条件和能力进行评估,并自行在备案系统中备案。

针对提供虚假材料的行为,办法提出,隐瞒有关情况或者提供虚假材料办理临床试验机构备案的,或者存在缺陷、不适宜继续承担临床试验的临床试验机构,省级以上食品药品监督管理部门按照《医疗器械监督管理条例》的规定进行处理。食药监总局取消其机构或相关专业的备案信息,通报国家卫计委,并进行公告。

据了解,办法自2018年1月1日起施行。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2010988, encodeId=1dbf2010988b4, content=<a href='/topic/show?id=192c424e930' target=_blank style='color:#2F92EE;'>#备案管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42479, encryptionId=192c424e930, topicName=备案管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Thu Apr 12 09:04:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958281, encodeId=63c819582817f, content=<a href='/topic/show?id=c54b21110f9' target=_blank style='color:#2F92EE;'>#两部委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21110, encryptionId=c54b21110f9, topicName=两部委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Tue Dec 05 22:04:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590928, encodeId=ab65159092832, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Sun Nov 26 16:04:00 CST 2017, time=2017-11-26, status=1, ipAttribution=)]
    2018-04-12 yahu
  2. [GetPortalCommentsPageByObjectIdResponse(id=2010988, encodeId=1dbf2010988b4, content=<a href='/topic/show?id=192c424e930' target=_blank style='color:#2F92EE;'>#备案管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42479, encryptionId=192c424e930, topicName=备案管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Thu Apr 12 09:04:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958281, encodeId=63c819582817f, content=<a href='/topic/show?id=c54b21110f9' target=_blank style='color:#2F92EE;'>#两部委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21110, encryptionId=c54b21110f9, topicName=两部委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Tue Dec 05 22:04:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590928, encodeId=ab65159092832, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Sun Nov 26 16:04:00 CST 2017, time=2017-11-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2010988, encodeId=1dbf2010988b4, content=<a href='/topic/show?id=192c424e930' target=_blank style='color:#2F92EE;'>#备案管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42479, encryptionId=192c424e930, topicName=备案管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Thu Apr 12 09:04:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958281, encodeId=63c819582817f, content=<a href='/topic/show?id=c54b21110f9' target=_blank style='color:#2F92EE;'>#两部委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21110, encryptionId=c54b21110f9, topicName=两部委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Tue Dec 05 22:04:00 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590928, encodeId=ab65159092832, content=<a href='/topic/show?id=f175424e6fe' target=_blank style='color:#2F92EE;'>#备案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42476, encryptionId=f175424e6fe, topicName=备案)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41f217885803, createdName=cenghis, createdTime=Sun Nov 26 16:04:00 CST 2017, time=2017-11-26, status=1, ipAttribution=)]
    2017-11-26 cenghis